NCT02476357

Brief Summary

Patients undergoing groin or axillary Radical lymph node dissection (RLND) or completion lymph node dissection (CLND, after positive sentinel lymph node biopsy (SLNB) for melanoma or breast cancer were randomized in a controlled trial for surgical dissection technique. Harmonic scalpel dissection were compared with classic dissection in term of lymphocoele and oedema.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

February 20, 2015

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 19, 2015

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

April 29, 2020

Completed
Last Updated

August 6, 2020

Status Verified

July 1, 2020

Enrollment Period

4.9 years

First QC Date

February 20, 2015

Results QC Date

March 4, 2020

Last Update Submit

July 29, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative Draining Time

    Duration (days) between surgery and removal of postoperative suction drain

    Lymph quantity measured every day. Drained removed when < 50 ml. per day for 2 consecutive days

Secondary Outcomes (1)

  • Daily Amount of Drained Lymph

    Lymph quantity measured every day, up to 50 days.

Study Arms (2)

Harmonic

ACTIVE COMPARATOR

Harmonic Scalpel (HS; Ethicon Endo-Surgery, Cincinnati, OH)

Device: Harmonic scalpel

Control

ACTIVE COMPARATOR

Monopolar scalpel and ligature

Device: Harmonic scalpel

Interventions

ControlHarmonic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All adult patients undergoing groin or axillary Radical lymph node dissection (RLND) or completion lymph node dissection (CLND), after positive sentinel lymph node biopsy (SLNB) for melanoma or breast cancer were included.

You may not qualify if:

  • Patient with a past medical history of contralateral lymph node dissection or other cause for lymphedema (trauma, deep venous thrombosis, radiotherapy, etc.) were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Visceral Surgery, University Hospital Center

Lausanne, Canton of Vaud, 1011, Switzerland

Location

Related Publications (1)

  • Gie O, Matthey-Gie ML, Marques-Vidal PM, Demartines N, Matter M. Impact of the Ultrasonic scalpel on the amount of drained lymph after axillary or inguinal lymphadenectomy. BMC Surg. 2017 Mar 21;17(1):27. doi: 10.1186/s12893-017-0222-1.

MeSH Terms

Conditions

LymphedemaLymphocele

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesCystsNeoplasms

Results Point of Contact

Title
Prof. Dr Med. Maurice MATTER
Organization
Lausanne University Hospita! and University of Lausanne

Study Officials

  • Maurice Matter, Prof

    University of Lausanne Hospitals

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
unblinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Monocentric, open, interventional, randomized with two arms 1:1
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 20, 2015

First Posted

June 19, 2015

Study Start

January 1, 2009

Primary Completion

December 1, 2013

Study Completion

December 31, 2017

Last Updated

August 6, 2020

Results First Posted

April 29, 2020

Record last verified: 2020-07

Locations